Carboxamide Spleen Tyrosine Kinase (Syk) Inhibitors: Leveraging Ground State Interactions To Accelerate Optimization.

作者: J. Michael Ellis , Michael D. Altman , Brandon Cash , Andrew M. Haidle , Rachel L. Kubiak

DOI: 10.1021/ACSMEDCHEMLETT.6B00353

关键词: Ames testSykSelectivityMoietyCarboxamideKinomeChemistryPotencyAmideStereochemistry

摘要: Optimization of a series highly potent and kinome selective carbon-linked carboxamide spleen tyrosine kinase (Syk) inhibitors with favorable drug-like properties is described. A pervasive Ames liability in an analogous nitrogen-linked was obviated by replacement moiety. Initial efforts lacked on-target potency, likely due to strain induced between the hinge binding amide solvent front heterocycle. Consideration ground state bound energetics allowed rapid realization improved substituents affording subnanomolar Syk potency high selectivity. These molecules were also devoid mutagenicity risk as assessed via test using TA97a Salmonella strain.

参考文章(17)
Jonathan W. Friedberg, Jeff Sharman, John Sweetenham, Patrick B. Johnston, Julie M. Vose, Ann LaCasce, Julia Schaefer-Cutillo, Sven De Vos, Rajni Sinha, John P. Leonard, Larry D. Cripe, Stephanie A. Gregory, Michael P. Sterba, Ann M. Lowe, Ronald Levy, Margaret A. Shipp, Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia Blood. ,vol. 115, pp. 2578- 2585 ,(2010) , 10.1182/BLOOD-2009-08-236471
Marina Ulanova, Florentina Duta, Lakshmi Puttagunta, Alan D Schreiber, A Dean Befus, None, Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis. Expert Opinion on Therapeutic Targets. ,vol. 9, pp. 901- 921 ,(2005) , 10.1517/14728222.9.5.901
Polly R. Pine, Betty Chang, Nathan Schoettler, Mona L. Banquerigo, Su Wang, Angela Lau, Feifei Zhao, Elliott B. Grossbard, Donald G. Payan, Ernest Brahn, Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. Clinical Immunology. ,vol. 124, pp. 244- 257 ,(2007) , 10.1016/J.CLIM.2007.03.543
Armando G. Villaseñor, Rama Kondru, Hoangdung Ho, Sandra Wang, Eva Papp, David Shaw, Jim W. Barnett, Michelle F. Browner, Andreas Kuglstatter, Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic Analysis of Three Inhibitor Complexes Chemical Biology & Drug Design. ,vol. 73, pp. 466- 470 ,(2009) , 10.1111/J.1747-0285.2009.00785.X
Robert L. Geahlen, Getting Syk: spleen tyrosine kinase as a therapeutic target Trends in Pharmacological Sciences. ,vol. 35, pp. 414- 422 ,(2014) , 10.1016/J.TIPS.2014.05.007
Kevin S. Currie, Jeffrey E. Kropf, Tony Lee, Peter Blomgren, Jianjun Xu, Zhongdong Zhao, Steve Gallion, J. Andrew Whitney, Deborah Maclin, Eric B. Lansdon, Patricia Maciejewski, Ann Marie Rossi, Hong Rong, Jennifer Macaluso, James Barbosa, Julie A. Di Paolo, Scott A. Mitchell, Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase Journal of Medicinal Chemistry. ,vol. 57, pp. 3856- 3873 ,(2014) , 10.1021/JM500228A
Mirza Suljagic, Pablo G. Longo, Sara Bennardo, Emerald Perlas, Giuseppe Leone, Luca Laurenti, Dimitar G. Efremov, The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling Blood. ,vol. 116, pp. 4894- 4905 ,(2010) , 10.1182/BLOOD-2010-03-275180
Neil S. Garton, Matthew Gray, Thomas G. Hayhow, Clare I. Hobbs, Emma Jones, Stuart Leach, Karen Leavens, Huw D. Lewis, Scott McCleary, Margarete Neu, Vipulkumar K. Patel, Alex G.S. Preston, Cesar Ramirez-Molina, Tracy J. Shipley, Philip A. Skone, Nick Smithers, Donald O. Somers, Ann L. Walker, Robert J. Watson, Gordon G. Weingarten, John Liddle, Francis L. Atkinson, Michael D. Barker, Paul S. Carter, Neil R. Curtis, Rob P. Davis, Clement Douault, Marion C. Dickson, Dorothy Elwes, Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor Bioorganic & Medicinal Chemistry Letters. ,vol. 21, pp. 6188- 6194 ,(2011) , 10.1016/J.BMCL.2011.07.082
Gebhard Thoma, Alexander B. Smith, Maurice J. van Eis, Eric Vangrevelinghe, Joachim Blanz, Reiner Aichholz, Amanda Littlewood-Evans, Christian C. Lee, Hong Liu, Hans-Günter Zerwes, Discovery and profiling of a selective and efficacious syk inhibitor. Journal of Medicinal Chemistry. ,vol. 58, pp. 1950- 1963 ,(2015) , 10.1021/JM5018863